{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:13:21Z","timestamp":1780913601255,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF16OC0021406"],"award-info":[{"award-number":["NNF16OC0021406"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18OC0031804"],"award-info":[{"award-number":["NNF18OC0031804"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["8020-00420B"],"award-info":[{"award-number":["8020-00420B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.atherosclerosis.2023.03.015","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T10:45:32Z","timestamp":1680000332000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease"],"prefix":"10.1016","volume":"372","author":[{"given":"Jeyanthini","family":"Risikesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Heeb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indumathi","family":"Kumarathas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian L.","family":"Funck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakel F.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Ringgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars P.","family":"Tolbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle L.","family":"Kanstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars C.","family":"Gormsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-5556","authenticated-orcid":false,"given":"S\u00f8ren","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.112","article-title":"The metabolic basis of nonalcoholic steatohepatitis","volume":"3","author":"Chakravarthy","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2011.04.007","article-title":"Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance","volume":"22","author":"Choi","year":"2011","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ehf2.13222","article-title":"Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues","volume":"8","author":"Itier","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.001979","article-title":"Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease","volume":"8","author":"Gran\u00e9r","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib6","article-title":"NAFLD and cardiovascular diseases: a clinical review","author":"Kasper","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc11-1820","article-title":"Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"35","author":"Bonapace","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib9","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s10620-009-0935-9","article-title":"Association between nonalcoholic fatty liver disease and coronary artery calcification","volume":"55","author":"Chen","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib10","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.12998\/wjcc.v8.i20.4688","article-title":"Relationship between non-alcoholic fatty liver disease and coronary heart disease","volume":"8","author":"Arslan","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","article-title":"Lipotoxic diseases","volume":"53","author":"Unger","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/hep.22105","article-title":"Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: another piece of the puzzle","volume":"47","author":"Bugianesi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","article-title":"Metabolic flexibility in health and disease","volume":"25","author":"Goodpaster","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib15","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI113822","article-title":"Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments","volume":"82","author":"Gertz","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/138161209787582101","article-title":"The heart metabolism: pathophysiological aspects in ischaemia and heart failure","volume":"15","author":"Abozguia","year":"2009","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib17","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.25548","article-title":"Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease","volume":"55","author":"Sullivan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/EJE-14-0333","article-title":"Ten weeks of aerobic training does not result in persistent changes in VLDL triglyceride turnover or oxidation in healthy men","volume":"171","author":"Nellemann","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib21","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1152\/ajpendo.00043.2014","article-title":"Kinetics and utilization of lipid sources during acute exercise and acipimox","volume":"307","author":"Nellemann","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1194\/jlr.M900021-JLR200","article-title":"Relationship between postabsorptive respiratory exchange ratio and plasma free fatty acid concentrations","volume":"50","author":"Jensen","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-0043-109561","article-title":"Measuring VLDL1-triglyceride and VLDL2-triglyceride kinetics in men: effects of dietary control on day-to-day variability","volume":"49","author":"Johansen","year":"2017","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/CS20070217","article-title":"Fasting in healthy subjects is associated with intrahepatic accumulation of lipids as assessed by 1H-magnetic resonance spectroscopy","volume":"114","author":"M\u00f8ller","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib25","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib26","first-page":"1723","article-title":"Quantitation of myocardial fatty acid metabolism using PET","volume":"37","author":"Bergmann","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1536012117734485","article-title":"Whole-body biodistribution, dosimetry, and metabolite correction of [(11)C]palmitate: a PET tracer for imaging of fatty acid metabolism","volume":"16","author":"Christensen","year":"2017","journal-title":"Mol. Imag."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2010.05.039","article-title":"Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals","volume":"139","author":"Iozzo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jc.2015-3476","article-title":"Impaired insulin suppression of VLDL-triglyceride kinetics in nonalcoholic fatty liver disease","volume":"101","author":"Poulsen","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib30","first-page":"E649","article-title":"A new correction factor for use in tracer estimations of plasma fatty acid oxidation","volume":"269","author":"Sidossis","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib31","first-page":"E431","article-title":"Validation of a new method for determination of free fatty acid turnover","volume":"252","author":"Miles","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib32","doi-asserted-by":"crossref","first-page":"E939","DOI":"10.1152\/ajpendo.00031.2011","article-title":"Effects of exercise on VLDL-triglyceride oxidation and turnover","volume":"300","author":"S\u00f8ndergaard","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib33","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.clinbiochem.2013.08.011","article-title":"Simultaneous determination of \u03b2-hydroxybutyrate and \u03b2-hydroxy-\u03b2-methylbutyrate in human whole blood using hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry","volume":"46","author":"S\u00f8rensen","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib34","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/dom.13244","article-title":"Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: a 3-month placebo-controlled clinical trial in patients with type 2 diabetes and healthy controls","volume":"20","author":"Gormsen","year":"2018","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib36","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1249\/00005768-199108000-00006","article-title":"Myocardial lactate metabolism during exercise","volume":"23","author":"Stanley","year":"1991","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib37","doi-asserted-by":"crossref","first-page":"E709","DOI":"10.1152\/ajpendo.00104.2006","article-title":"Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women","volume":"292","author":"Qvisth","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/oby.2011.290","article-title":"Impaired insulin-mediated antilipolysis and lactate release in adipose tissue of upper-body obese women","volume":"20","author":"Nellemann","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2020.11.028","article-title":"Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance","volume":"74","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0008-6363(96)00245-3","article-title":"Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions","volume":"33","author":"Stanley","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","article-title":"Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients","volume":"68","author":"Lee","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib42","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10620-016-4040-6","article-title":"Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease","volume":"61","author":"Mantovani","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib43","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","article-title":"Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging","volume":"54","author":"Rijzewijk","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib44","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","article-title":"Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes","volume":"291","author":"Lautam\u00e4ki","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s001250051597","article-title":"Myocardial fatty acid oxidation in patients with impaired glucose tolerance","volume":"44","author":"Knuuti","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib46","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diabetes.48.6.1245","article-title":"Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid","volume":"48","author":"Turpeinen","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib47","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00005768-199803000-00006","article-title":"Adaptations in control of blood flow with training: splanchnic and renal blood flows","volume":"30","author":"McAllister","year":"1998","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib49","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1172\/JCI16253","article-title":"Energy expenditure, sex, and endogenous fuel availability in humans","volume":"111","author":"Nielsen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2023.03.015_bib50","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.M600175-JLR200","article-title":"Energy expenditure, insulin, and VLDL-triglyceride production in humans","volume":"47","author":"Gormsen","year":"2006","journal-title":"J. Lipid Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502300117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502300117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:27:07Z","timestamp":1762187227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502300117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":50,"alternative-id":["S002191502300117X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.03.015","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}